Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.
about
Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review)A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.Stem cell biology in thyroid cancer: Insights for novel therapiesClinical review: The emerging cell biology of thyroid stem cells.Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancerA novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.Detection of thyroid cancer stem cells in papillary thyroid carcinoma.Stemness in human thyroid cancers and derived cell lines: the role of asymmetrically dividing cancer stem cells resistant to chemotherapy.In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subsetThe role of cell lines in the study of neuroendocrine tumors.Stem cells and cancer stem-like cells in endocrine tissues.Thyroid C-Cell Biology and Oncogenic Transformation.Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest.Expression of CD133 in differentiated thyroid cancer of young patients.Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.The GDNF Family: A Role in Cancer?Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
P2860
Q27015644-71F72644-07CC-41F7-AB61-F8F1AA41F1EFQ34153520-9493B70E-4E06-4410-9029-FB3CE5301BD4Q34259125-617BA5AE-8AEA-4CF4-9988-9FCCEB890C45Q35198499-3E736905-33C7-4329-BFC3-5C3049B93805Q35317540-F4AAEAA6-CC11-47C4-ADDD-E676EB5E1079Q35561120-D204DC2A-CC3A-4892-B598-B94D4E37CE34Q37554739-D4A82412-E199-486C-9D3A-FCC9A168F49EQ37616850-7E390E1E-1B56-465A-85AC-50A11BAF6E74Q37630091-6D4204CF-82DE-435A-9B07-DD820FF0A615Q38005913-E0ACCC79-904B-43B8-AE68-FFCE8F8CA26AQ38084129-DA6B4A58-BC44-4DC7-9562-BBCEDD74AB57Q38614485-3C074E29-005B-480F-8CD3-DD2739FA006CQ38703728-39BBFD2F-1199-47CF-96DE-AF43787AFF49Q38782254-EAEB43BA-DDC4-499E-9C95-F1D79F163B6FQ38900211-D939BA76-00BC-4F41-8AE7-770E242A5336Q39354316-19E38A16-CDC7-4CE1-961A-033839C09F20Q41251561-5CD6C553-1BE9-4674-8E29-66691C3C9A24Q47137356-D0925372-8A57-4957-9EF0-DCF09737DD1BQ53199483-B768C37B-7376-40A8-A3AC-BE32C5E3C392
P2860
Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@ast
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@en
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@nl
type
label
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@ast
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@en
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@nl
prefLabel
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@ast
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@en
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@nl
P2093
P2860
P356
P1476
Medullary thyroid carcinoma ce ...... n ret proto-oncogene activity.
@en
P2093
P2860
P304
P356
10.1210/JC.2009-1485
P407
P577
2009-11-06T00:00:00Z